期刊论文详细信息
Cancer Medicine
Gamma Knife radiosurgery to four or more brain metastases in patients without prior intracranial radiation or surgery
Eric Ojerholm2  John Y. K. Lee1  James Kolker2  Robert Lustig2  Jay F. Dorsey2 
[1] Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania;Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania
关键词: Gamma Knife radiosurgery;    radiation therapy neoplasm metastases;    stereotactic radiosurgery;    survival;    tumor volume;   
DOI  :  10.1002/cam4.206
来源: Wiley
PDF
【 摘 要 】

Abstract

Data on stereotactic radiosurgery (SRS) for four or more metastases are limited. Existing studies are confounded by significant proportions of patients receiving prior whole-brain radiation therapy (WBRT) or concurrent WBRT with SRS. Furthermore, published results disagree about the impact of tumor volume on overall survival. A retrospective review identified 38 patients without prior intracranial radiation or surgery who received Gamma Knife (GK) as sole treatment to ≥4 brain metastases in a single session. Twenty-eight cases with follow-up imaging were analyzed for intracranial progression. Prognostic factors were examined by univariate (log-rank test) and multivariate (Cox proportional hazards model) analyses. Common primary tumors were non-small cell lung (45%), melanoma (37%), and breast (8%). Cases were recursive partitioning analysis class II (94%) or III (6%). Patients harbored a median five tumors (range 4–12) with median total tumor volume of 1.2 cc. A median dose of 21 Gy was prescribed to the 50% isodose line. Patients survived a median 6.7 months from GK. Local treatment failure occurred in one case (4%) and distant failure in 22 (79%). On multivariate analysis, total tumor volume ≥3 cc was significantly associated with distant failure and worsened overall survival (P = 0.042 and 0.040). Fourteen patients (37%) underwent salvage WBRT at a median 10.3 months from GK and seven patients received repeat GK. GK as sole initial treatment for four or more simultaneous metastases spares some patients WBRT and delays it for others. Increased total tumor volume (≥3 cc) is significantly associated with worsened overall survival.

【 授权许可】

CC BY   
© 2014 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

【 预 览 】
附件列表
Files Size Format View
RO202107150001450ZK.pdf 871KB PDF download
  文献评价指标  
  下载次数:10次 浏览次数:4次